1 / 8

The Endometrial Regenerative Cell (ERC) - universal donor adult stem cell product

The Endometrial Regenerative Cell (ERC) - universal donor adult stem cell product. Dr. Alan Lewis CEO May 10, 2013. Safe Harbor Statement.

robyn
Télécharger la présentation

The Endometrial Regenerative Cell (ERC) - universal donor adult stem cell product

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Endometrial Regenerative Cell (ERC) - universal donor adult stem cell product Dr. Alan Lewis CEO May 10, 2013

  2. Safe Harbor Statement The statements and discussions contained in this presentation that are not historical facts constitute forward-­‐ looking statements. These can be identified by the use of forward-­‐looking words, such as “believes”, “expects”, “may”, “intends”, “anticipates”, “plans”, “estimates”, or any other analogous or similar expressions intended to identify forward-­‐looking statements. These forward-­‐looking statements and estimates as to future performance, estimates as to future valuations, and other statements contained herein regarding matters that are not historical facts, are only predictions and actual events or results may differ materially. We cannot assure or guarantee that any future results described in this presentation will be achieved, and actual results could vary materially from those reflected in such forward-­‐looking statements. Information contained in this presentation has been complied from sources believed to be credible and reliable. However, we cannot guarantee such credibility and reliability. The forecasts and projections of events contained herein are based upon subjective valuations, analyses, and personal opinions. INFORMATION REGARDING DISCLOSURES This presentation does not constitute an offer to sell or a solicitation of an offer to purchase any securities of any nature whatsoever, nor do the contents of the presentation constitute legal, tax, or business advice. Information included herewith has been obtained from the Company and other sources believed to be reliable, but the accuracy or completeness of such information is not guaranteed by, and should not be construed as a representation by the Company. Any representations and warranties will be contained only in a definitive agreement signed by the investor and the Company.

  3. About MEDISTEM • Clinical-stage Stem Cell Company • Endometrial Regenerative Cells (ERCs) • FDA approved for clinical trials • Derived from the endometrium (lining of the uterus) – nature’s regenerative powerhouse – specialized for making blood vessels (angiogenesis) and suppressing autoimmunity • Universal application, safe for everyone • In Clinic Targeting $6.9 billion Cardiovascular Market • Congestive Heart Failure – Phase II Trial began 2012 – 16 Patients Treated • Critical Limb Ischemia – FDA-approved Phase I/II trial • Late Stage Preclinical Type 1 Diabetes Program • Trading on Pink Sheets under ticker: MEDS

  4. Leadership Team • Alan Lewis, Ph.D.Chief Executive Officer • Former CEO Ambit Biosciences • Former CEO JDRF Foundation • Former CEO Novocell (Viacyte) • Former CEO Signal Pharmaceuticals • (acquired by Celgene) • Thomas Ichim, Ph.D.President, Chief Scientific Officer • Founded MedvaxPharma Corp • Founded ToleroTech, Inc. • Founded bioRASI • Founded OncoMune • Inventor of over 30 patents • Don Dickerson, M.B.A.Chief Financial Officer • Former Division CFO at JP Morgan • Former Director of Strategy and Finance at Boeing • Senior Manager of Finance at Dell and Boeing

  5. Endometrial Regenerative Cells

More Related